US Trial Shows Gilead's Remdesivir Drug Works Best in Coronavirus Patients Who Require Extra Oxygen Gilead said it expects results from its own study of remdesivir in patients with moderate COVID-19 at the end of this month. Gilead said it expects results from its own study of remdesivir in patients with moderate COVID-19 at the end of this month.
Gilead said it expects results from its own study of remdesivir in patients with moderate COVID-19 at the end of this month.from Top World News- News18.com https://ift.tt/2WXmCpD
https://ift.tt/2SpBVES
Gilead said it expects results from its own study of remdesivir in patients with moderate COVID-19 at the end of this month.
Comments
Post a Comment